Introduction
T he first cells appearing in the mammalian germ cell lineage are the PGCs, a prerequisite to sustain the continuation of species from one generation to the next. Upon spontaneous differentiation of hESCs as embryoid bodies (EBs), several early PGC markers STELLA (Dppa3), FRAGILIS (Ifitm3), cKIT (kit), and late PGC marker VASA (Ddx4) have been detected [1] . Subsequently, several attempts have been made to develop more efficient protocols for deriving germ cells in vitro from ESCs. BMP4 was found to play a prominent role in inducing germ cell gene expression, especially of the postmigratory germ cell marker VASA in in vitro derived PGCs from hESCs [2] . Efforts were also made to develop an efficient step-wise protocol by supplementing hESCs with a growth factor cocktail in a time-dependent manner mimicking the in vivo environment [3] [4] [5] . In addition, it was found that coculture of hESCs with Sertoli cells or human fetal gonadal cells boosted germ cell differentiation [6, 7] based on the expression of early and late germ cell markers. hESCs were also genetically manipulated by overexpressing DAZL to induce germ cell differentiation or transfected with VASApEGFP-1 reporter construct to identify and isolate hESCderived PGCs in vitro [8, 9] . Culture strategies, such as EB culture, adherent culture, colony size, frequency of refreshment of cultures, are all shown to have an effect on directed differentiation of hESCs towards PGCs [6, 10] .
In all the studies undertaken for hESC differentiation towards PGCs, multiple hESC lines were employed. More evidence suggests that hESC lines differ from each other in their lineage-specific differentiation potential [11, 12] . These differences between hESC lines may be due to several factors, such as embryo quality, derivation technique, and inherent genetic identity or used culture conditions during derivation and culture. Therefore, it becomes a necessity to screen for the ideal hESC line before starting differentiation. It is also suggested that derivation of hESC lines in conditions specific towards lineage of interest might help yield valuable results [11, 12] ; however, this has not been investigated yet.
The TGFb signaling pathway is composed of two main branches, namely the TGFb/Activin/Nodal branch involving SMAD2/3 proteins, which maintain hESC pluripotency, and the SMAD1/5/8 branch acting downstream of BMP4 and GDF ligands during differentiation [13, 14] . Activin A is one of the important members of the TGFb superfamily. In situ ligand binding in male Sprague-Dawley rats has shown the ability of Activin A to bind to germ cells [15] . In juvenile mice testis, in vivo progression of germ cell maturation was influenced by Activin A bioactivity during the onset of spermatogenesis [16] . It was found to be the first Sertoli cell by-product that was involved in differentiation of male germ cells in meiotic state [17] . In fetal mouse testis, it keeps a balance between Sertoli and germ cell proliferation [18] . In humans, during the onset of primordial follicle formation, it aids in germ cell proliferation and survival [19] and also regulates follicle formation and growth in vitro [20] . Recently, Activin A was shown to suppress the retinoic acid inhibitor CYP26B1 and to help inducing meiosis [21] .
It is becoming increasingly clear that hESCs are in fact similar to mEpiSCs, sharing properties, such as dependence on TGFb/Activin signaling to maintain their pluripotency and ability to differentiate into PGC-like cells upon exposure to BMP4 [22] [23] [24] [25] . In connection to this, our group recently showed that the human ICM outgrowth first undergoes a transient epiblast-like state before hESCs are established, which substantiates their primed pluripotency status [26] . mEpiSCs, which are derived in the presence of Activin A [27] , appear to retain characteristics of the original epiblast and show strong potential to generate PGC-like cells in vitro, which are able to further develop into late germ cells [24] . In addition, male and female germ cell specification was induced in mESCs and mouse induced pluripotent stem cells by culturing them in Activin A to obtain early pregastrulating epiblast-like cells (EpiLCs), which gave rise to PGClike cells in the presence of BMP4 [28, 29] .
The results that we present here indicate that hESC derivation in the presence of Activin A has a significant impact on the state of the derived hESC lines. We showed that addition of Activin A during hESC derivation induced increased germ cell differentiation potential compared to hESC lines derived in standard conditions without Activin A.
Materials and Methods

Ethical permission
All patients donating embryos signed informed consents before their IVF/ICSI cycle. Approval for the current study was obtained from the Ghent University Hospital Ethical Committee (2009/281) and from the Belgian Federal Ethical Committee on Embryo Research (Adv-030).
hESC derivation and culture
To derive our hESC lines in both Activin A and standard derivation conditions, all human embryos donated for research were randomized and day 6 human blastocysts were scored according to the grading system of Stephenson and colleagues [30] . Blastocysts with grade A and B inner cell mass (large and distinct inner cell mass) [31, 32] were exposed to Acidic Tyrode's solution (Cat No. T1788; Sigma) to remove the zona pellucida, washed in hESC media and plated on a feeder layer of CD1 mouse embryonic fibroblasts (MEFs) pretreated with mitomycin-C (Cat No. M4287; Sigma). For standard hESC lines UGent11-5, UGent11-6, and UGent11-7, culturing from blastocyst to hESC stage was carried out in a low-oxygen environment at 37°C, consisting of 6% CO2, and 5% O2, using standard hESC medium [26, 33] . Within approximately 7 days, hESCs outgrowths were cut mechanically, transferred to freshly inactivated MEFs, and continually mechanically passaged until several colonies appeared. After this, hESCs were maintained and split 1:6 onto freshly inactivated MEFs every 5-6 days using 1 mg/mL collagenase type IV (Cat No. 17104-019; Invitrogen) with daily medium changes to keep hESCs in an undifferentiated state.
For deriving the hESC lines UGent11-4-ActA and UGent12-3-ActA, the medium was supplemented with 20 ng/mL Activin A (Cat No. 338-AC-010; R&D Systems) from the day 6 blastocyst stage onwards until hESC passage 6. After that, the lines were further cultured in standard hESC media without Activin A.
Karyotyping
Early passage hESCs were grown to confluency and exposed to colcemid (1:100 in salt solution, Cat No. 15210-057 Karyomax; Invitrogen) to arrest the cells at metaphase. They were then treated with 0.25% trypsin-EDTA (Cat No. 25200-056; Invitrogen) and exposed to hypotonic HCl solution (Cat No. T-3038; Sigma) followed by fixation in 1:3 methanol/ acetic acid solution (Cat No. 1.06009.1000, Merck; Cat No. A6283, Sigma). Karyotype analysis was performed for 10 numerical spreads of metaphase and 3 complete karyograms using G-banding technique as previously described [34] .
Alkaline phosphatase live staining
Undifferentiated hESCs were washed twice with DMEM/ F-12 (Cat No. 31331-028; Invitrogen) for 2-3 min. They were then incubated in 1 · alkaline phosphatase (AP) Live Stain (Cat No.A14353; Molecular Probes, Life Technology) for 30 min. Next, hESCs were washed twice with DMEM/F-12 for 5 min to remove AP Live Stain. Fresh DMEM/F-12 was added to fluorescent-labeled hESC cultures and they were visualized using standard FITC filter by fluorescence microscopy.
UGent11-7) after passage 6. All hESC lines were used between passages 20-25 to maintain homogeneity and to understand the impact of derivation conditions on PGC differentiation of hESCs. Also, we performed karyotyping of all hESC lines before starting our experiments. All hESC lines were karyotypically normal. Briefly, hESCs were washed with 1· phosphate buffered saline (PBS), incubated with collagenase for 6 min and subsequently gently scraped from the culture flasks with a flattened needle. Collagenase was neutralized with differentiation medium (80% KO-DMEM, 20% fetal bovine serum, NEAA, L-glutamine, penicillin/ streptomycin and b-mercaptoethanol). hESCs were allowed to settle by gravity for 15-20 min and were subsequently resuspended in germ cell differentiation medium consisting of differentiation medium supplemented with 50 ng/mL BMP4 (Cat No. 314-BP-010; R&D Systems). Cells were then transferred onto 24-well Costar Ultra Low Attachment Clear Flat Bottom plates (Cat No. 3473; Corning) and allowed to differentiate for 3, 7 and 14 days in low-oxygen conditions. Germ cell differentiation medium was replaced every alternate day (1 mL per well). For dose-response studies of BMP4, the hESC line UGent11-4-ActA was differentiated as EBs up to day 7 in differentiation medium containing 10 ng/mL BMP4, 50 ng/mL BMP4, or 100 ng/ mL BMP4.
Immunocytochemistry
EBs and hESCs were fixed in 4% paraformaldehyde in PBS at 4°C and stored in 100% methanol at -20°C and in 1· PBS at 4°C, respectively. EBs were rehydrated through a series of methanol/water solutions and washed in PBST (PBS + 0.1% Tween-20) twice for 10 min. Next, they were rinsed in TBST (Tris-buffered saline + 0.1% TritonX-100, pH 7.4) and blocked in 0.5%BSA/TBST blocking solution at 4°C overnight before incubation with primary antibody for 2 days at 4°C (rotating). They were washed in TBST five times for 30 min at room temperature and incubated with secondary antibody overnight at 4°C (rotating). EBs were again washed in TBST (5 times for 30 min), mounted on glass slides using Vectashield with DAPI (Vector Laboratories Ltd.).
hESCs were rinsed in 1· PBS, permeabilized in 0.1%Tri-tonX-100/1· PBS for 8 min, then washed in 1· PBS, and blocked in 0.05% Tween-20/1% BSA/1· PBS blocking solution for 1 h at room temperature. hESCs were then incubated with primary antibody overnight at 4°C, washed three times in 1· PBS, and incubated with secondary antibody for 1 h at room temperature. They were then washed again three times in 1· PBS and subsequently mounted on glass slides using Vectashield with DAPI.
Primary antibodies used were goat anti-OCT4 ( 
Western blotting
Whole cell lysates were prepared from second trimester fetal testis and BMP4-treated EBs (day 7) derived from UGent11-4-ActA and UGent11-6 hESC lines. Twenty micro gram proteins from each sample were loaded per lane on a 10% SDS-PAGE gel. Next, proteins were transferred to a nitrocellulose membrane. Transferred blots were then blocked in PBT (1· PBS + 0.3% Tween) with 1% BSA for 1 h at RT followed by incubation in primary antibody (1:500, rabbit-anti VASA, Cat No. ab13840, Abcam; 1:5000, rabbitanti b-TUBULIN, Cat No. ab6046, Abcam) overnight at 4°C. Blots were then washed in PBT thrice for 5 min and incubated in secondary antibody (1:20000, goat-anti-rabbit-HRP, Cat No. ab6721, Abcam) for 1 h at RT. Blots were again washed as before, developed using SuperSignal West Dura Chemiluminescent Substrate (Cat No. 34076; Thermoscientific) and were captured using the Bio-Rad VersaDoc imaging system with Bio-Rad Quantity One software.
RNA isolation and reverse transcription quantitative polymerase chain reaction
hESCs and EBs from days 3, 7 and 14 were collected and lysed in 1 mL TRIzol (Cat No. 15596-026; Invitrogen). Total RNA was purified from the inorganic phase using the RNeasy Mini Kit (Cat No. 74104; Qiagen). cDNA was For all hESC lines, after 14 days of differentiation as EBs, ectoderm marker NESTIN and endoderm markers GATA4 and GATA6 upregulated significantly compared to OCT4, P < 0.05; mesoderm marker HAND1 also showed significant upregulation compared to OCT4, P £ 0.001; (ii) Differentiation of all hESCs as EBs on day 3, day 7 and day 14. Scale bar, 100 mm.
(Continued) synthesized using the iScript Advanced cDNA Synthesis Kit for RT-qPCR (Cat No. 170-8842; Biorad). cDNA concentration was determined with the Quant-iT Oligreen ssDNA Assay Kit (Cat No. O11492; Invitrogen) on a Tecan fluorescence reader using Magellan software.
Real time polymerase chain reaction (PCR) amplification of cDNA was performed for VASA, OCT4, cKIT, NANOG (Taqman Gene Expression Assays; Applied Biosystems), STELLA, FRAGILIS, SSEA1, SOX2 (Real-time Ready Assays; Roche). For studying the differentiation of day 14 EBs into the three germ layers (differentiated in medium without bFGF), genes analyzed included ectodermal genes NESTIN, PAX6, mesodermal genes HAND1, PECAM1, endodermal genes GATA4, GATA6 and pluripotency gene OCT4. The reference genes were GAPDH, B2M and RPL13A (Table 1) . Each quantitative PCR (qPCR) reaction included 20 ml mastermix and 10 ng cDNA. The mastermix consisted of gene specific primers and iTAQ supermix with ROX (Cat No. 172-5855; Biorad) or iTAQ SYBR Green Supermix with ROX (Cat No. 172-5850; Biorad).
The qPCR machine employed was the ABI Prism 7000 Sequence Detection System (Applied Biosystems). The thermocycling conditions were as follows: 2 min at 95°C followed by 45 cycles of 15 s at 95°C followed by 1 min at 60°C. All samples were analysed in biological and technical triplicates. 11-week fetal testis was used as positive control and no cDNA (water) samples or no RT (RNA) samples were used as negative controls. Ct values were normalized Results hESC lines derived in the presence of Activin A are pluripotent and show increased propensity towards PGC differentiation Based on the fact that mEpiSCs are derived in the presence of Activin A [27] and have been previously shown to have high potential to generate PGC-like [24] cells, we also added Activin A at 20 ng/mL to human embryos at the blastocyst stage to determine whether this would influence the in vitro PGC differentiation potential of the derived hESC lines. We were able to successfully derive two hESC lines in the presence of Activin A: UGent11-4-ActA (XX) and UGent12-3-ActA (XY). The other hESC lines UGent11-5 (XX), UGent11-6 (XX) and UGent11-7 (XY) used in this study were all derived conventionally in the absence of Activin A. All hESC lines were pluripotent, expressing OCT4 and NANOG (Fig. 1a) , AP positive (Fig. 1b), karyotypically normal (Fig. 1c) , and could be differentiated as EBs expressing markers of the three germ layers (Fig. 1d) . When SB431542, an inhibitor of Activin A [35] , was added at the blastocyst stage, in vitro progression to the PICMI stage was observed; however, no hESC lines could be derived (results not shown). This may likely be due to the fact that SB431542 blocks the TGFb/Activin/Nodal signaling pathway, which is indispensible to maintain the primed status of pluripotency in hESCs [36] . Hence, this may be the probable cause for the successful derivation of hESCs
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Ato the housekeeping genes and the final values were described as
FIG. 2.
Gene expression profiles of all hESC lines upon germ cell-directed differentiation as EBs in the presence of bone morphogenic protein 4 (BMP4) for early primordial germ cell (PGC) markers STELLA, cKIT, FRAGILIS (a-c), late PGC marker VASA (d), pluripotency markers OCT4, SOX2, NANOG (e-g), and the differentiation marker SSEA1 (h). Activin Aderived hESC lines UGent11-4-ActA and UGent12-3-ActA show significantly higher expression for STELLA and cKIT at day 0 and significant upregulation of VASA at day 7, when FRAGILIS is downregulated. For all hESC lines, pluripotency markers OCT4, SOX2, NANOG were significantly downregulated, and SSEA1 expression increased as differentiation proceeded from day 0 to day 14. STELLA, cKIT: UGent11-4-ActA (a¢) compared to standard hESC lines at day 0 (a), P £ 0.001; UGent12-3-ActA (b¢) compared to standard hESC lines at day 0 (b), P £ 0.001; FRAGILIS: Day 7 UGent12-3-ActA EBs (a¢) compared to day 0 and day 3 EBs (a), P < 0.05; VASA: Day 7 UGent 11-4-ActA EBs (a¢) compared to day 7 EBs of standard hESC lines (a) P £ 0.001; Day 7 UGent12-3-ActA EBs (b¢) compared to day 7 EBs of standard hESC lines (b) P £ 0.001; OCT4, SOX2, NANOG: for all hESC lines, differentiation as EBs from day 0 to day 14, P £ 0.001; SSEA1: P < 0.05.
(Continued) 3146 DUGGAL ET AL.
in the presence of Activin A and failure to generate any hESC lines upon the inhibition of TGFb/Activin/Nodal signaling pathway by SB431542; thus, further emphasizing the intricate nature of the hESC derivation process. Next, we investigated PGC differentiation potential of both Activin A-derived hESC lines and standard hESC lines. At day 0, Activin A-derived hESCs showed significantly higher STELLA expression compared to standard hESCs (7.4 and 9.2-fold increase for UGent11-4-ActA and UGent12-3-ActA, respectively; P £ 0.001) (Fig. 2a) . The cKIT expression pattern resembled that of STELLA with high expression levels in Activin A-derived hESC at day 0 compared to standard hESCs (Fig. 2b) . Hence, these Activin A-derived hESC lines show high inherent expression levels of early PGC markers, which may prone them towards germ cell differentiation. This is further corroborated by the fact that Activin A-derived hESCs showed significant upregulation of VASA compared to standard hESCs on day 7 EBs (10 and 7.5-fold increase in UGent11-4-ActA and UGent12-3-ActA, respectively; P £ 0.001). This upregulation of VASA in differentiating Activin A-derived hESCs corresponded to a downregulation in FRAGILIS expression. From day 7 EBs to day 14 EBs, expression levels of both FRAGILIS and VASA were maintained in these differentiating hESCs. In contrast, standard hESCs showed a steady rise in FRAGILIS expression from day 0 to day 14 EBs, while VASA continued to be expressed at a low level (Fig. 2c, d ). The pluripotency markers OCT4, SOX2 and NANOG were significantly downregulated in all differentiating hESC lines, while SSEA1 continued to rise from day 0 to day 14 EBs (Fig. 2e-h) .
As day 7 marked the critical time point for rise in VASA at the mRNA level in EBs, we immunostained those of the Activin A-derived hESC line UGent11-4-ActA and the standard hESC line UGent11-6 at this time point to check for VASA and OCT4 presence at the protein level. UGent11-4-ActA showed higher expression of VASA compared to UGent11-6 ( Fig. 3a and Supplementary Fig. S1 ; Supplementary Data are available online at www.liebertpub.com/scd). VASA localized to the nucleus and to the cytoplasm of both dividing and nondividing cells. Very little or no OCT4 expression was seen in day 7 UGent11-4-ActA EBs, while UGent11-6 EBs continued to show a few OCT4-positive cells with no or very few cells expressing VASA only in the nucleus (Fig. 3b) . It is possible that these OCT4-positive cells of UGent11-6 represent early PGCs. These results were further confirmed by western Blot analysis ( Fig. 3c and Supplementary Fig. S2 ).
ng/mL BMP4 is sufficient to direct hESC differentiation towards PGC-like cells
Various reports have studied the dose dependent effect of BMP4 in inducing germ cell gene expression in ESCs DERIVATION IN ACTIVIN A[2,3,37,38] . In EBs generated from mESCs, a biphasic response in gene expression was seen upon addition of BMP4 from 20 ng/mL to 500 ng/mL. Here 50 ng/mL, 100 ng/mL and 200 ng/mL showed a gradual increase in early OCT4
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+ PGC population, whereas 200 ng/mL led to its decrease and induced mesoderm-directed differentiation [38] . PGC-directed differentiation of bone marrow mesenchymal stem cells also showed a BMP4-associated dose dependent increase in VASA expression where 100 ng/mL proved to be the best concentration compared to 25 ng/mL and 50 ng/mL [37] . A cocktail of BMPs, including BMP4, BMP7, and BMP8b supplemented at 100 ng/mL has also proven to be highly beneficial in germ cell differentiation of hESCs compared to 1 ng/mL and 10 ng/ mL of BMP4 [2] . Thus, we wanted to determine the optimum concentration of BMP4 for its impact on in vitro PGC differentiation of our Activin A-derived hESC lines. To test this, UGent11-4-ActA was differentiated as EBs in the absence of BMP4, and at 10 ng/mL, 50 ng/mL or 100 ng/mL BMP4 up to day 7. It was observed that 50 ng/mL and 100 ng/mL BMP4 led to significantly higher upregulation of STELLA and VASA expression as compared to 10 ng/mL BMP4 or its absence. However, 50 ng/mL and 100 ng/mL concentrations did not show a significant difference between each other with respect to their effect on STELLA and VASA expression. Hence, 50 ng/mL BMP4 was employed as a standard dosage in our experiments. OCT4 expression was unaffected by different BMP4 concentrations (Fig. 4) .
Activin A-derived hESC lines showed high expression of the endodermal marker GATA-6 in the presence of BMP4 and exhibited active TGFb/Activin signaling As the Activin A-derived hESC lines were exposed to Activin A during their derivation, we wanted to check whether TGFb/Activin signaling is active during their differentiation towards PGC-like cells. Translocation of pSMAD2/3, an active component of TGFb/Activin signaling, from cytoplasm to the nucleus helps in regulating gene expression [13] . Our immunocytochemistry results showed that phosphorylated SMAD2/3 is present in day 7 EBs of UGent11-4-ActA when VASA is upregulated, while it remained absent or at reduced levels in UGent11-6 (Fig. 5a-c) . However, this needs to be further investigated.
As Activin A and BMP4 together are known to induce differentiation towards the endodermal lineage [39] , and to further emphasize the fact that derivation in Activin A has an effect on the derived hESC line, we checked whether these hESC lines were also giving rise to endoderm on day 7 EBs, while being differentiated in germ cell differentiation media supplemented with BMP4. We observed GATA-6 positive cells covering the surface of a large majority of EBs in UGent11-4-ActA (Fig. 6a) , as well as nuclear pSMAD1/5/8 ( Fig. 6b) indicative of their responsiveness to BMP4. Hence, as both pSMAD2/3 and pSMAD1/5/8 are present in differentiating Actvin A-derived hESCs, this further confirms that Activin A-derived hESCs are responsive to both Activin and BMP signaling upon differentiation, which may explain their increased potency to differentiate into PGC-like cells.
Discussion
Both mouse EpiLCs [28, 29] and mEpiSCs are prone towards germ cell differentiation [24] and are derived in similar culture conditions as mostly used for hESC derivation, except for the extra supplementation of Activin A [27, 28] . We successfully showed that supplementing Activin A during derivation of hESC lines can generate pluripotent hESCs, which display predisposition for differentiation towards the PGC-like lineage. Although Activin A has been shown to support pluripotency and self-renewal [40] of hESC culture in feeder-free conditions, derivation of most hESC lines has been performed in the presence of factors, such as bFGF and human recombinant leukemia inhibitory factor [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] without Activin A. In 2010, a xeno-free hESC derivation medium called RegES medium was developed, which contained only 5 ng/mL Activin A. However, this medium was solely employed to derive hESC lines in xeno-free conditions for clinical purpose and their lineage-specific differentiation potential was not compared to standard derived hESC lines [51, 52] .
All hESC lines are known to share similar morphology, growth pattern, and expression of pluripotency markers; however, variations amongst hESC lines exist at the transcriptional level with culture conditions being one of the crucial causative factors [45, 46, 53, 54] . For example, differential expression of 1417 genes was observed upon the culture of HS237 hESC line in medium with or without serum [55] . Hence, variations in hESC lines could be a direct result of the culture environment the embryo was exposed to during the hESC derivation process. In fact, considerable changes at the molecular level have been shown during the process of hESC derivation from blastocyst embryos. These changes have been highlighted in a study by our group [26] , where a comparative analysis was performed between ICM, post ICM intermediate (PICMI), and hESCs. It was observed that as the ICM progresses towards hESCs, the intermediate PICMI stage is formed, characterized by the expression of both early and late epiblast markers. Interestingly, germ cell markers, such as cKIT and FRAGILIS also increased along with Nodal/Activin signaling during the PICMI stage. These markers are again downregulated in hESCs although still higher in expression compared to ICM [26] . Thus, exposing hESCs during their derivation to 20 ng/mL Activin A, similar to mouse EpiLCs and mEpiSCs, boosted their germ cell differentiation potential unlike the other hESC lines, which were derived using conventional methods in the absence of Activin A. On the contrary, we observed that addition at the blastocyst stage of SB431542, an inhibitor of Activin A [35] , failed to result in hESC lines, further emphasizing the unique significance of the hESC derivation stage. Germ cell differentiation of hESCs is commonly assessed by determining expression levels of widely used germ cell markers, such as STELLA, FRAGILIS, cKIT, SSEA1, and VASA [56, 57] . Our Activin A-derived hESC lines showed significantly higher base levels of STELLA and cKIT as compared to standard derived hESC lines. This may indicate an increased predisposition of these hESC lines towards the germ cell lineage. Moreover, it was recently reported that STELLA plays an active role in inducing germ cell directed differentiation of hESCs [58] . Also, we observed that FRA-GILIS continued to rise up to day 7 EBs and as it is subsequently downregulated, there is a concomitant rise in VASA expression. Hence, this expression pattern may indicate the completion of the PGC specification process and that the cells are in a transition between migratory and premeiotic state. For the standard hESC lines, early PGC markers, such as STELLA, FRAGILIS, and cKIT were lowly expressed in the beginning and their expression rose as differentiation progresses after BMP4 supplementation with no or very little expression of VASA. Thus, the conventionally derived hESC lines without Activin A appear to require longer periods for the PGC specification process. We also observed a decrease in the pluripotency markers OCT4, SOX2 and NANOG accompanied by a rise in SSEA1 levels indicating that differentiation has occurred successfully in all hESC lines. Higher expression of VASA was also observed at the protein level in Activin A-derived hESC lines compared to standard hESC lines. Although VASA expression is predominantly localized to the cytoplasm in germ cells, it has also been found in the cell nucleolus of hESC-derived germ cells as described by West and colleagues [59] . Similar to these observations, we also observed both cytoplasmic and nuclear localization of VASA, which may be indicative for the different time points of germ cell differentiation. Standard hESC lines failed to show either of these expression patterns and instead continued to express Oct4; thus, again pointing to the fact that these cell lines may still be in the stage of PGC specification and need extra signals from the environment to continue their lineage progression into late PGCs.
BMPs are known to play an indispensible role for the generation and specification of PGCs. As the in vivo PGCinducing capacity of BMPs can be extrapolated in vitro, several studies have used BMP4 as a prerequisite factor for differentiation of pluripotent stem cells into germ cells [2, 5, 8, 56] . An important fact is that hESCs respond to BMP4 in a dose-dependent manner. Kee and colleagues observed that adding BMP4 at 1 ng/mL, 10 ng/mL and 100 ng/mL corresponded with a significant rise in expression of VASA [2] . Directed differentiation of bone marrow mesenchymal stem cells towards germ cells was also accompanied by significant upregulation of VASA when the BMP4 concentration was increased from 25 ng/mL to 100 ng/mL [37] . Similarly, we also observed that BMP4 had a dose-dependent effect on PGC differentiation as 50 ng/mL and 100 ng/mL BMP4 significantly upregulated 
FIG. 4.
BMP4 dose-response study on day 7 EBs derived from the Activin A-derived hESC line UGent11-4-ActA for the early PGC marker STELLA, the late PGC marker VASA and the pluripotency marker OCT4. BMP4 is used at concentrations of 10 ng/mL, 50 ng/mL, and 100 ng/mL. STELLA: 50 ng/mL BMP4 (a¢) compared to 10 ng/mL BMP4 and -BMP4 (a), P < 0.05; 100 ng/mL BMP4 (b¢) compared to 10 ng/mL and -BMP4 (b¢), P < 0.05. VASA: 50 ng/mL BMP4 (a¢) compared to 10 ng/mL BMP4 and -BMP4 (a), P < 0.05; 100 ng/mL BMP4 (b¢) compared to 10 ng/mL and -BMP4 (b¢), P < 0.05.
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VASA and STELLA expression compared to 10 ng/mL BMP4 or its absence. It has been observed in mice that BMP4 interacts with the ALK2 receptor in visceral endoderm and conditions the epiblast to form PGCs. In fact, removal of visceral endoderm completely inhibited the formation of PGCs [60] . During gastrulation, extraembryonic visceral endoderm is replaced by definitive endoderm [61] and it has been recently observed that the combination of Activin A and BMP4 results in approximately 20% increase in the formation of definitive endoderm when compared to Activin A alone [61] . Upon differentiation of our Activin A-derived hESCs as EBs in the presence of BMP4, high expression of the endoderm marker GATA-6 was observed at the same time point when VASA was significantly upregulated in our EB cultures (at day 7). BMP4 and TGFb/Activin signaling were simultaneously active in Activin A-derived hESCs lines due to nuclear localization of pSMAD1/5/8 and pSMAD2/3, respectively. In contrast, no or very low levels of pSMAD2/3 were seen in standard derived hESC lines.
Thus, as TGFb/Activin signaling plays a role in early cell fate decision, BMP4 and endoderm development are responsible for PGC induction and formation [14, 39, 60, 62, 63] ; hence, the presence of all these factors in our Activin A-derived hESCs might be responsible for increased differentiation competency towards the germ cell lineage. Collectively, our results further reiterate the notion that Activin A induced hESC derivation helps to generate a pluripotent cell line optimum for studying in vitro differentiation into the germ cell lineage.
Conclusion
The heterogeneity amongst different hESC lines has a significant impact on their differentiation potential. We have successfully shown that the hESC derivation process has profound consequences for the subsequent differentiation potential of the resulting hESC lines. In our study, we have extrapolated the Activin A containing culture conditions used for mEpiSC derivation and generation of mouse EpiLCs to hESC derivation. We were able to show that these Activin A-derived hESC lines have increased propensity towards germ cell differentiation compared to standard hESC lines derived without Activin A. Future research will focus on detailed analysis and comparison of Activin A-derived hESC lines at genome-wide transcriptomics and epigenomic level to standard derived hESC lines and validating the interaction between Activin signalling and germ cell differentiation in vitro. We also propose that a differentiation-oriented derivation strategy of hESC lines may hold a crucial key to success for efficient lineage-specific differentiation. 
